Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Two Dose Levels of Eicosapentaenoic Acid (EPA) on Apoptosis and Cell Proliferation in the Colonic Mucosa of Patients With a History of Colonic Polyps.

NCT00432913 is registered in ClinicalTrials.gov with S.L.A. Pharma AG as lead sponsor.

NCT NCT00432913
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00432913 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Two Dose Levels of Eicosapentaenoic Acid (EPA) on Apoptosis and Cell Proliferation in the Colonic Mucosa of Patients With a History of Colonic Polyps.
Lead sponsor
S.L.A. Pharma AG
Phase
Phase 2/3
Overall status
Completed
Start date
October 31, 2006
Completion date
June 30, 2008
Enrollment
120 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

adenomatous polyps